In The News Posted March 4, 2019 Share Posted March 4, 2019 TOKYO, March 4, 2019 /PRNewswire/ -- AGC Inc. based in Tokyo announced on March 4 the completion of its acquisition of Spain's synthetic pharmaceutical active ingredient manufacturer, Malgrat Pharma Chemicals, S.L.U. (hereinafter referred to as MPC). The transaction had been previously... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.